ACS report: Lung cancer deaths plunge as survival doubles
-
By
-
Andrea Surnit
-
September 28, 2026
-
6 min
By
Andrea Surnit
September 28, 2026
Misako Nagasaka, MD, PhD shared how precision oncology has fundamentally shifted the landscape through the identification of actionable genomic targets for lung cancer treatment.
June 25, 2026
Several FDA decisions across multiple specialties are expected this month.
August 28, 2026